Askanase, A. D., Tang, W., Zuraw, Q., Gordon, R., Brotherton, B., & Merrill, J. T. (2023). Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE. Lupus Science & Medicine, 10(1), e000875. https://doi.org/10.1136/lupus-2022-000875

Zhang, S., Jiang, S., Deng, N., Zheng, B., Li, T., & Liu, R. H. (2022). Phytochemical Profiles, Antioxidant Activity and Antiproliferative Mechanism of Rhodiola rosea L. Phenolic Extract. Nutrients, 14(17), 3602. https://doi.org/10.3390/nu14173602

Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M. B., Clarke, A. E., Ramsey-Goldman, R., Gordon, C., Petri, M. A., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M. A., Peschken, C. A., Isenberg, D. A., Rahman, A., Manzi, S., Jacobsen, S., Lim, S., Vollenhoven, R. van, … Bernatsky, S. (2021). 801 Factors associated with SLE flares after HCQ taper, discontinuation or maintenance in the SLICC inception cohort: lower education linked with higher flare risk. Abstracts, A24.2-A25. https://doi.org/10.1136/lupus-2021-lupus21century.38